Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionThe Journal of infectious diseases, 2021-02, Vol.223 (2), p.197-205 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa618 ;PMID: 33535236Full text available |
|
2 |
Material Type: Article
|
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysViruses, 2020-05, Vol.12 (5), p.513 [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;Attribution ;2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12050513 ;PMID: 32384820Full text available |
|
3 |
Material Type: Article
|
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreakNature communications, 2020-09, Vol.11 (1), p.4378-4378, Article 4378 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18178-1 ;PMID: 32873791Full text available |
|
4 |
Material Type: Article
|
Structure-based design of stabilized recombinant influenza neuraminidase tetramersNature communications, 2022-04, Vol.13 (1), p.1825-1825, Article 1825 [Peer Reviewed Journal]2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-29416-z ;PMID: 35383176Full text available |
|
5 |
Material Type: Article
|
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Scientific reports, 2021-02, Vol.11 (1), p.4290-4290, Article 4290 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-83730-y ;PMID: 33619344Full text available |
|
6 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in micenpj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518Full text available |
|
7 |
Material Type: Article
|
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationCell reports (Cambridge), 2023-12, Vol.42 (12), p.113552-113552, Article 113552 [Peer Reviewed Journal]2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2023.113552 ;PMID: 38096058Full text available |
|
8 |
Material Type: Article
|
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based DesignFrontiers in immunology, 2021-06, Vol.12 [Peer Reviewed Journal]Copyright © 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.710263 ;PMID: 34267764Full text available |
|
9 |
Material Type: Article
|
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationJCI insight, 2021-11, Vol.6 (22) [Peer Reviewed Journal]2021 Cagigi et al. 2021 Cagigi et al. ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.151463 ;PMID: 34665783Full text available |
|
10 |
Material Type: Article
|
Quadrivalent influenza nanoparticle vaccines induce broad protectionNature (London), 2021-04, Vol.592 (7855), p.623-628 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Apr 22, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03365-x ;PMID: 33762730Full text available |
|
11 |
Material Type: Article
|
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077Full text available |
|
13 |
Material Type: Article
|
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesImmunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1680-1692.e8 [Peer Reviewed Journal]Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2022.07.015 ;PMID: 35977542Full text available |
|
14 |
Material Type: Article
|
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityNature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199Full text available |
|
15 |
Material Type: Article
|
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogensCell reports. Medicine, 2022-10, Vol.3 (10), p.100780, Article 100780 [Peer Reviewed Journal]Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100780 ;PMID: 36206752Full text available |
|
16 |
Material Type: Article
|
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infectionThe Journal of infectious diseases, 2020-09 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;EISSN: 1537-6613 ;PMID: 33000143Full text available |
|
17 |
Material Type: Web Resources
|
Journey and Transformation: Visual narrative by Deleah PettieDigital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesbioRxiv, 2021-032021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesbioRxiv, 2021-022021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2bioRxiv, 2020-082020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395Digital Resources/Online E-Resources |